Cargando…

A Novel Association between YKL-40, a Marker of Structural Lung Disease, and Short Telomere Length in 10-Year-Old Children with Bronchopulmonary Dysplasia

Extremely preterm infants are born with immature lungs and are exposed to an inflammatory environment as a result of oxidative stress. This may lead to airway remodeling, cellular aging and the development of bronchopulmonary dysplasia (BPD). Reliable markers that predict the long-term consequences...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henckel, Ewa, James, Anna, Konradsen, Jon R, Nordlund, Björn, Kjellberg, Malin, Berggren-Broström, Eva, Hedlin, Gunilla, Degerman, Sofie, Bohlin, Kajsa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912154/ https://www.ncbi.nlm.nih.gov/pubmed/33498968 http://dx.doi.org/10.3390/children8020080

Ejemplares similares

YKL‐40 is a proposed biomarker of inflammation and remodelling elevated in children with bronchopulmonary dysplasia compared to asthma
por: James, Anna J., et al.
Publicado: (2020)

Lung function development after preterm birth in relation to severity of Bronchopulmonary dysplasia
por: Um-Bergström, Petra, et al.
Publicado: (2017)

Hematopoietic cellular aging is not accelerated during the first 2 years of life in children born preterm
por: Henckel, Ewa, et al.
Publicado: (2020)

Increased cytotoxic T-cells in the airways of adults with former bronchopulmonary dysplasia
por: Um-Bergström, Petra, et al.
Publicado: (2022)

The cytokine interleukin-26 as a biomarker in pediatric asthma
por: Konradsen, Jon R., et al.
Publicado: (2016)

First week of life respiratory management and pulmonary ventilation/perfusion matching in infants with bronchopulmonary dysplasia: a retrospective observational study
por: Kjellberg, Malin, et al.
Publicado: (2022)

Changes in Antisecretory Factor in Human Milk During the Postpartum and Length of Gestation
por: Gustafsson, Anna, et al.
Publicado: (2021)

Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999)

YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Pulmonary outcomes in adults with a history of Bronchopulmonary Dysplasia differ from patients with asthma
por: Um-Bergström, Petra, et al.
Publicado: (2019)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009)

Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

Long Leukocyte Telomere Length at Diagnosis Is a Risk Factor for Dementia Progression in Idiopathic Parkinsonism
por: Degerman, Sofie, et al.
Publicado: (2014)

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
por: Shao, Rong, et al.
Publicado: (2009)

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
por: Shao, Rong
Publicado: (2013)

Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization
por: Shao, Rong, et al.
Publicado: (2015)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
por: Schroder, Jakob, et al.
Publicado: (2020)

Effect of Vitamin D on YKL-40: Rat Hypercholesterolemia Model
por: Kocabas, Rahim
Publicado: (2023)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Pulmonary Hemosiderosis in Children with Bronchopulmonary Dysplasia
por: Kurahara, David, et al.
Publicado: (2014)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Hospital management of severe bronchopulmonary dysplasia
por: Moretti, Corrado, et al.
Publicado: (2015)

Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia
por: Podraza, Wojciech, et al.
Publicado: (2018)

The rate and pattern of bronchopulmonary dysplasia in Kuwait
por: Al-Essa, Mazen, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_qq90nhpj9e6id66bqqg74fd497